Artelo Biosciences Inc banner

Artelo Biosciences Inc
NASDAQ:ARTL

Watchlist Manager
Artelo Biosciences Inc Logo
Artelo Biosciences Inc
NASDAQ:ARTL
Watchlist
Price: 3.76 USD -3.59% Market Closed
Market Cap: $7.6m

Profitability Summary

Artelo Biosciences Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Artelo Biosciences Inc

Margins Comparison
Artelo Biosciences Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Artelo Biosciences Inc
NASDAQ:ARTL
7.6m USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
930.7B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
581.6B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
256.9B CHF
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.7B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
222.2B GBP
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.1B USD
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Artelo Biosciences Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Artelo Biosciences Inc
NASDAQ:ARTL
7.6m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
930.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
581.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
256.9B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
222.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Artelo Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett